抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產品編號 | 圖片 | 產品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
CUG，98% | C16H16O10 | |||
|
|
|||||
|
PF-477736，98% | C22H25N7O2 | |||
|
|
|||||
|
Sodium picosulfate，99% | C18H13NO8S2.2Na | |||
|
|
|||||
|
Histatin 5，98% | C133H195N51O33 | |||
|
|
|||||
|
4-Ethoxy-3-Hydroxybutyranilide，98% | C12H17NO3 | |||
|
|
|||||
|
Aripiprazole-d8，98% | C23H19D8Cl2N3O2 | |||
|
|
|||||
|
BRD7552,PDX1轉錄因子誘導劑，≥98%(HPLC) | C33H33N3O15 | |||
|
|
|||||
|
Molidustat，98% | C13H14N8O2 | |||
|
|
|||||
|
|
Sal003，98% | C19H16Cl4N2OS | |||
|
|
|||||
|
|
XL413，99% | C14H13Cl2N3O2 | |||
|
|
|||||
|
Nifedipine-d6，98% | C17H12D6N2O6 | |||
|
|
|||||
|
莫吉司坦，≥99% | C16H21NO5S | |||
|
|
|||||
|
PIM447，98% | C24H23F3N4O | |||
|
|
|||||
|
Doxylamine (D5 succinate)，98% | C21H23D5N2O5 | |||
|
|
|||||
|
Gadodiamide (hydrate)，98% | C16H28GdN5O9 | |||
|
|
|||||
|
Tolterodine，94% | C22H31NO | |||
|
|
|||||
|
鹽酸奈他地爾(AR-13324)，≥98% | C28H29Cl2N3O3 | |||
|
|
|||||
|
SAMS PEPTIDE，98% | C74H131N29O18S2 | |||
|
|
|||||
|
|
MI-2,Menin-MLL 相互作用抑制劑，≥98% | C18H25N5S2 | |||
|
|
|||||
|
ENMD-2076 L-(+)-Tartaric acid，98% | C25H31N7O6 | |||
|
|
|||||
|
Win 55,212-2 Mesylate，≥98%(HPLC) | C28H30N2O6S | |||
|
|
|||||
|
|
LM10，98% | C11H8FN5 | |||
|
|
|||||
|
Pimecrolimus，98% | C43H68ClNO11 | |||
|
|
|||||
